Cancer Genetics

Malignancy is a hereditary sickness brought about by amassing of DNA changes and epigenetic adjustments prompting excessive cell multiplication and neoplasm arrangement. The objective of oncogenomics is to distinguish new oncogenes or tumor silencer qualities that may give new bits of knowledge into malignancy conclusion, anticipating clinical result of diseases and The achievement of focused malignancy treatments, for example, Gleevec, Herceptin and Avastin raised the desire for oncogenomics to explain new focuses for disease treatment. The worldwide disease diagnostics market size was esteemed at USD 144. 4 billion of every 2018 and is relied upon to enroll a CAGR of 7.0% over the estimate time frame.

  • Human genome project
  • Whole genome sequencing
  • Operomics
  • Oncogenomics
  • Point mutations
  • Cancer genome sequencing

Tracks

Cancer Genetics

Share this page on your timeline

Submit Abstract
Register Now
+1 (506) 909-0537